Comments on: Withania somnifera Root vs Leaf Extracts: What Clinical Trials Reveal About Different Plant Parts

By: Laura Young

Laura Young — Sun, 06 Sep 2026 11:29:52 +0000

Makes sense.

Suresh Yadav — Thu, 03 Sep 2026 21:58:50 +0000

root powder vs standardized extract is where most confusion starts. this post should say labels carefully

Sanjay Gupta — Sun, 30 Aug 2026 22:03:54 +0000

@Smita at what withanolide percentage is an extract considered ‘standardized’? I see brands claiming anywhere from 2.5% to 35%.

Laura Williams — Thu, 27 Aug 2026 14:44:08 +0000

Doing this.

Sanjay Hall — Sun, 23 Aug 2026 15:03:04 +0000

@Ryan does the adaptogenic benefit plateau at a certain dose, or do higher doses continue to show additional stress-reduction benefits?

Ryan Allen — Sun, 23 Aug 2026 06:32:11 +0000

at what withanolide percentage is an extract considered ‘standardized’? I see brands claiming anyehere from 2.5% to 35%.

Naveen Kumar — Fri, 21 Aug 2026 11:07:30 +0000

withania leaf extract worries me more than root. safety section needs to be very direct

Mark Taylor — Thu, 20 Aug 2026 21:04:32 +0000

@Pooja will try!

Eric Brown — Wed, 19 Aug 2026 14:57:01 +0000

the ‘clinical trials reveal’ framing oversells the evidence base. most trials are small, shorr-duration, and industry-funded.

Mark Bennett — Wed, 19 Aug 2026 11:27:55 +0000

It’s interesting that the leaf’s higher withaferin A content links it to cytotoxic research rather than everyday adaptogenic use.